We serve Chemical Name:2-Boc-2,8-Diazaspiro[4.5]decane CAS:336191-17-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![2-Boc-2,8-Diazaspiro[4.5]decane](https://a.dearchem.com/CAS2/336191-17-4.png)
Chemical Name:2-Boc-2,8-Diazaspiro[4.5]decane
CAS.NO:336191-17-4
Synonyms:1,1-Dimethylethyl 2,8-diazaspiro[4.5]decane-2-carboxylate;2-Boc-2,8-Diazaspiro[4.5]decane;2-Methyl-2-propanyl 2,8-diazaspiro[4.5]decane-2-carboxylate;2,8-Diazaspiro[4.5]decane-2-carboxylic acid, 1,1-dimethylethyl ester;tert-Butyl 2,8-diazaspiro[4.5]decane-2-carboxylate;T6M DXTJ D-& CT5N CXTJ AVOX1&1&1
Molecular Formula:C13H24N2O2
Molecular Weight:240.342
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:337.0±35.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.515
PSA:41.57000
Exact Mass:240.183777
LogP:1.46
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1,1-Dimethylethyl 2,8-diazaspiro[4.5]decane-2-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Methyl-2-propanyl 2,8-diazaspiro[4.5]decane-2-carboxylate Use and application,tert-Butyl 2,8-diazaspiro[4.5]decane-2-carboxylate technical grade,usp/ep/jp grade.
Related News: The new R&D People and Culture Strategy aims to make UK the most ideal place for research and innovation, led by individuals, universities and businesses, and funders. YTTERBIUM IODIDE manufacturers Earlier this year, the US Food and Drug Administration approved Verquvo to reduce the risk of cardiovascular death and heart failure hospitalisation, following a hospitalisation for heart failure or need for outpatients intravenous (IV) diuretics in adults with symptomatic chronic heart failure and ejection fraction less than 45%. rel-(2R,3R)-3-(2-methoxyphenyl)-2-methyl-3-(naphthalen-1-yl)-2-(pyrrolidine-1-carbonyl)propanenitrile suppliers Novartis and GSK carried out a swap of its vaccine and cancer drugs back in 2015. GSK paid $5.25 billion to Novartis for its vaccine business, and Novartis sent $16 billion for GSK’s oncology programs. Tafinlar and Mekinist had already been granted FDA approval at the time of that deal, and as a part of that deal, Novartis agreed to divest its own BRAF and MEK inhibitors to avoid creating a monopoly. (E)-2,3,4,5-tetrahydroxy-24,34,44,54-decaoxida-2,4-diene vendor & factory.
